Physician profile
Prabhakara Kunamneni
NPI 1972545093
$3,561.64
in general payments reported to CMS, 2019-2025
16 companies · $199 in 2025
The $199 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,423 · 2020: $416 · 2021: $699 · 2022: $332 · 2023: $338 · 2024: $154 · 2025: $199.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $692.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $691.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $918.16 | 2019-2020 | |
| Penumbra, INC. | $726.42 | 2020-2023 | Penumbra System |
| Bard Peripheral Vascular, INC. | $358.86 | 2020-2022 | |
| Cook Medical LLC | $289.75 | 2019-2025 | Advance, Zilver Ptx, Icast Covered Stent System, 6mmx22mmx120cm |
| Cvrx, INC. | $285.77 | 2023-2024 | Barostim Neo System |
| Abbott Laboratories | $272.36 | 2019-2025 | Diamondback Peripheral, Thoratec Heartmate 3 Lvas Implant Kit |
| Philips North America LLC | $206.68 | 2019 | |
| Medtronic, INC. | $108.21 | 2021-2024 | Resolute Onyx |
| Novo Nordisk INC | $99.00 | 2019 | |
| Cardiovascular Systems INC. | $87.49 | 2022 | |
| Edwards Lifesciences Corporation | $74.25 | 2020-2024 | |
| Boston Scientific Corporation | $44.80 | 2025 | Lux-Dx Insertable Cardiac Monitor, General - Brady |
| Esperion Therapeutics, INC. | $28.11 | 2022 | |
| Amgen INC. | $27.13 | 2019 | |
| Angiodynamics, INC. | $20.76 | 2025 | Auryon Laser System 100-120 Vac |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $13.89 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Prabhakara Kunamneni listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.